华东数控(002248) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥60,338,203.65, a decrease of 14.85% compared to ¥70,857,273.85 in the same period last year[2] - Net profit attributable to shareholders was ¥4,097,049.65, down 17.89% from ¥4,989,457.31 year-on-year[2] - The net profit after deducting non-recurring gains and losses increased by 61.00% to ¥2,765,811.12, compared to ¥1,717,939.17 in the previous year[2] - Basic and diluted earnings per share were both ¥0.013, down 18.75% from ¥0.016[2] - Net profit for the period was ¥4,019,397.15, down from ¥4,681,514.68, reflecting a decrease of approximately 14.1% year-over-year[18] - The company reported a decrease in basic and diluted earnings per share to ¥0.013 from ¥0.016, a decline of approximately 18.8%[18] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥5,039,453.40, a decline of 145.56% from ¥11,060,898.29 in the same period last year[2] - Cash flow from operating activities showed a net outflow of ¥5,039,453.40 compared to a net inflow of ¥11,060,898.29 in the previous period[20] - The company generated ¥30,030,441.01 in cash inflows from operating activities, down from ¥35,980,421.82, a decrease of about 16.5% year-over-year[20] - Cash and cash equivalents at the end of the period increased to ¥17,970,637.73 from ¥7,997,925.33, indicating a significant improvement in liquidity[20] - The company's cash and cash equivalents increased to ¥25,333,761.08 from ¥16,686,252.43 at the beginning of the year, representing a growth of approximately 51.5%[13] Assets and Liabilities - Total assets at the end of the reporting period were ¥531,028,501.30, an increase of 0.59% from ¥527,931,064.89 at the end of the previous year[2] - The company's total liabilities decreased to ¥463,280,118.50 from ¥464,560,635.81, a reduction of approximately 0.3%[16] - Total assets at the end of the reporting period amounted to ¥531,028,501.30, slightly up from ¥527,931,064.89 at the beginning of the year[16] - Shareholders' equity attributable to the parent company increased by 6.99% to ¥68,191,099.24 from ¥63,735,493.02 at the end of the previous year[2] - The total equity attributable to the parent company increased to ¥68,191,099.24 from ¥63,735,493.02, an increase of about 6.4%[16] - The company reported an accumulated deficit of ¥1,045,512,232.44, slightly improved from ¥1,049,609,282.09 at the beginning of the year[16] Operating Costs and Expenses - Total operating costs decreased to ¥56,970,550.81 from ¥69,368,290.54, a reduction of about 17.8% year-over-year[18] - Research and development expenses increased to ¥2,080,598.39 from ¥1,949,961.96, marking an increase of about 6.7% year-over-year[18] - Cash paid for purchasing goods and services increased by 102.12% to ¥19,559,991.19 from ¥9,677,609.65 in the same period last year[6] Shareholder Information - The total number of common shareholders at the end of the reporting period is 60,656[9] - The largest shareholder, Weihai Weigao International Medical Investment Holdings, holds 17.50% of shares, totaling 53,825,800 shares[9] Government Support - The company received government subsidies amounting to ¥332,764.32, which was significantly higher than the previous year's ¥150,000.00, reflecting a 121.84% increase[6] - The company reported a 300.93% increase in tax refunds received, totaling ¥799,838.88 compared to ¥199,495.67 in the previous year[6]